OpenAI Acquires Orchestra Bio to Build AI Agents for Drug Development Workflows
OpenAI has acquired Orchestra Bio, a platform for coordinating biopharma R&D, integrating it with Rosalind, its life sciences AI suite.
OpenAI has acquired Orchestra Bio, a platform for coordinating biopharma R&D, integrating it with Rosalind, its life sciences AI suite.